Shepherd Partners with Intel to Enhance its Endpoint Protection Suite with Hardware-based Ransomware Detection
Shepherd, a leading IoT and enterprise endpoint security and management vendor headquartered…
Race the Light shines a spotlight on charity partnership
Thursday 13 March, 2025 The Chilterns Neuro Centre was thrilled to be…
Indianapolis Prize Names Ugandan Wild Cat Protector Winner of Second Emerging Conservationist Award
INDIANAPOLIS, March 4, 2025 /PRNewswire/ -- The Indianapolis Prize, the world's leading award…
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Company Announcement COPENHAGEN, Denmark; February 28, 2025 – Genmab A/S (Nasdaq: GMAB)…
U.S. Institute of Peace Announces Visaka Dharmadasa the Fifth Annual Women Building Peace Award Laureate
WASHINGTON, Feb. 27, 2025 /PRNewswire/ -- The U.S. Institute of Peace (USIP)…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data…